Abstract
As practices have rapidly evolved over the past 20 years into various areas of specialization, pharmacy managers have recognized different needs of specialists. Accelerated development of antineoplastic and biotechnological agents has propelled oncology practitioners and educators to keep with the pace of these developments. The rapid growth of biotechnology will play the most important role in shaping the direction of oncology pharmacy in the next decade. The development of recombinant growth factors, such as erythropoietin and granulocyte-macrophage colony-stimulating factor as well as interleukins, interferons, and monoclonal antibodies, heralds a new era in the treatment and diagnosis of cancers. Pharmacy managers can assist this process by supporting clinicians and educators with excellent distributive services, readily accessible drug information resources, and the capability of attending continuing educational programs in the areas of biotechnology and new drug delivery systems.
Get full access to this article
View all access options for this article.